Your session is about to expire
← Back to Search
Device
Mucosal Impedance Probe for Acid Reflux
N/A
Waitlist Available
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up values will be obtained at conclusion of egd, an expected average of 5 minutes
Awards & highlights
Summary
The investigators are looking at a novel approach to measuring gastroesophageal reflux disease (GERD) damage and reducing the need for costly and less optimal testing presently used for diagnostic and treatment purposes. The investigators will be using three custom mucosal impedance (MI) catheters, each designed to measure at slightly different spacing on the esophagus.
Eligible Conditions
- Acid Reflux
- Esophagitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ values will be obtained at conclusion of egd, an expected average of 5 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~values will be obtained at conclusion of egd, an expected average of 5 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mucosal Impedance Values
Trial Design
1Treatment groups
Experimental Treatment
Group I: Mucosal Impedance ProbeExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard of care endoscopy
2012
N/A
~430
Find a Location
Who is running the clinical trial?
Vanderbilt UniversityLead Sponsor
709 Previous Clinical Trials
6,143,279 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger